Literature DB >> 22483194

Analysis of polarized secretion of fucosylated alpha-fetoprotein in HepG2 cells.

Tsutomu Nakagawa1, Kenta Moriwaki, Naoko Terao, Takatoshi Nakagawa, Yasuhide Miyamoto, Yoshihiro Kamada, Eiji Miyoshi.   

Abstract

Fucosylated alpha-fetoprotein (AFP) is a more specific biomarker for hepatocellular carcinoma (HCC) than AFP. However, the mechanisms underlying the increase in fucosylated AFP in sera of HCC patients remain largely unknown. Recently, we reported that fucosylation is a possible signal for the secretion of hepatic glycoproteins into bile and that the fucosylation-based sorting machinery might be disrupted in the liver bearing HCC. In this study, we investigated the selective secretion of fucosylated AFP into bile canaliculus (BC) structures of the human hepatoma cell line HepG2. The proportion of fucosylated AFP in BC structures was higher than that in the medium, as judged by lectin affinity electrophoresis. Suppression of fucosylation by the double knock-down of GDP-mannose-4,6-dehydratase and the human homologue of GDP-4-keto-6-deoxymannose-3,5-epimerase-4-reductase, which contribute to the synthesis of GDP-fucose, a donor substrate for fucosyltransferases, did not decrease the proportion of fucosylated AFP in BC structures but decreased this proportion in conditioned medium. Furthermore, increased AFP fucosylation was observed in medium, but not in BC structures, upon adding free fucose. These results suggest that saturation of fucosylated AFP in BC structures is accompanied by its increase in conditioned medium, probably leading to increased fucosylated AFP in sera of HCC patients.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22483194     DOI: 10.1021/pr201154k

Source DB:  PubMed          Journal:  J Proteome Res        ISSN: 1535-3893            Impact factor:   4.466


  5 in total

Review 1.  Proteomic and genomic studies of non-alcoholic fatty liver disease--clues in the pathogenesis.

Authors:  Jun Wei Lim; John Dillon; Michael Miller
Journal:  World J Gastroenterol       Date:  2014-07-14       Impact factor: 5.742

Review 2.  Glycosylation in cancer: its application as a biomarker and recent advances of analytical techniques.

Authors:  Yoshimi Haga; Koji Ueda
Journal:  Glycoconj J       Date:  2022-02-14       Impact factor: 2.916

3.  Serum Fucosylated Haptoglobin as a Novel Diagnostic Biomarker for Predicting Hepatocyte Ballooning and Nonalcoholic Steatohepatitis.

Authors:  Yoshihiro Kamada; Maaya Akita; Yuri Takeda; Shin Yamada; Hideki Fujii; Yoshiyuki Sawai; Yoshinori Doi; Hitomi Asazawa; Kotarosumitomo Nakayama; Kayo Mizutani; Hironobu Fujii; Takayuki Yakushijin; Masanori Miyazaki; Hisao Ezaki; Naoki Hiramatsu; Yuichi Yoshida; Shinichi Kiso; Yasuharu Imai; Norifumi Kawada; Tetsuo Takehara; Eiji Miyoshi
Journal:  PLoS One       Date:  2013-06-21       Impact factor: 3.240

Review 4.  Application of glycoscience to the early detection of pancreatic cancer.

Authors:  Eiji Miyoshi; Yoshihiro Kamada
Journal:  Cancer Sci       Date:  2016-09-02       Impact factor: 6.716

5.  Fucosylation is a promising target for cancer diagnosis and therapy.

Authors:  Eiji Miyoshi; Kenta Moriwaki; Naoko Terao; Cheng-Cheng Tan; Mika Terao; Tsutomu Nakagawa; Hitoshi Matsumoto; Shinichiro Shinzaki; Yoshihiro Kamada
Journal:  Biomolecules       Date:  2012-01-30
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.